Dawn Svoronos
CIK 1574579 · last filed 2026-06-03
Dawn Svoronos is a corporate insider who has filed 58 SEC Form 4 insider transactions across 7 companies since 2013. The most recent filing, for XENE, was dated Jun 3, 2026. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.62M
7
58
-$1.28M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XENE | Director | 27,645 | $52.10 | $1.44M | -$826.7K | 13 | 2026-06-03 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | 0 | $4.36 | $0 | $225.9K | 9 | 2025-12-10 |
| ACELYRIN, Inc. (SLRN) Delisted | Director | 15,000 | $2.27 | $34.0K | $270.0K | 2 | 2024-06-11 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | Director | 0 | $68.49 | $0 | -$273.4K | 7 | 2022-10-06 |
| PTCT | Director | 29,017 | $75.14 | $2.18M | $235.8K | 12 | 2022-06-10 |
| ENDOCYTE INC (ECYT) Delisted | Director | 0 | — | — | $0 | 2 | 2018-12-21 |
| MEDIVATION, INC. (MDVN) Delisted | Director | 21,206 | — | — | -$910.9K | 10 | 2016-06-23 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | XENE | Mixed | +1,229 | -$75.6K | EDGAR |
| 2025-12-10 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Mixed | −5,000 | $0 | EDGAR |
| 2025-06-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | XENE | Grant (A) | — | $0 | EDGAR |
| 2025-05-23 | — | Disp (D) | −15,000 | $0 | |
| 2024-06-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | ACELYRIN, Inc. (SLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-05 | XENE | Grant (A) | — | $0 | EDGAR |
| 2023-08-24 | XENE | Sell (S) | −25,000 | -$967.5K | EDGAR |
| 2023-06-13 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |